European Association for the Study of Diabetes

16/04/2026

🚀 It's kick-off day for the EASD Diabetes Technology School 2026!

We're thrilled to welcome participants from around the world (Armenia, Austria, Bulgaria, Canada, Georgia, Germany, Greece, India, Ireland, Italy, Kazakhstan, Lithuania, Luxembourg, Malta, Mexico, Poland, Portugal, Romania, South Africa, Switzerland, Turkey, the UAE and Uzbekistan) all gathered in Vienna for three transformative days exploring the frontiers of diabetes technology from the latest innovations to real-world clinical applications.

Guided by an exceptional faculty led by Prof. Julia Mader, alongside Profs. Pieter Gillard, Julia Ware and Pratik Choudhary, this year's cohort will dive deep into cutting-edge tools and strategies that are reshaping how we deliver diabetes care.

Lectures, hands-on sessions, cross-specialty collaboration - the knowledge and connections built this week will travel back to every corner of the world 🌍💡

Wishing all participants an inspiring and rewarding course!

See full programme : https://www.easd.org/education/meetings-and-courses/diabetes-technology-school/diabetes-tech-school-2026/

We are most grateful for the generous support of our partners.

16/04/2026

🏆 We're delighted to announce Prof. Dr. Klaus Kaestner (University of Pennsylvania) as the recipient of the 20th EASD Albert Renold Prize, awarded in recognition of his outstanding contributions to the pathophysiology and treatment of diabetes mellitus.

Prof. Dr. Kaestner uses cutting-edge mouse genetic approaches, including gene targeting and tissue-specific gene ablation, to unravel the molecular mechanisms behind the development and physiology of the liver, pancreas and gastrointestinal tract. His work has deepened our fundamental understanding of diabetes and opened new avenues for research.

Learn more 👉 https://www.easd.org/prizes/albert-renold/

We look forward to his award ceremony and lecture at and warmly invite you to join us in celebrating his achievements 👏

The EASD Albert Renold Prize is generously supported by Lilly Diabetes International.

15/04/2026

👉 The second EASD Early Career Academy Meeting took place at the Deutsches Diabetes Zentrum (German Diabetes Centre) in Düsseldorf. Like last year, the programme comprised outstanding scientific lectures as well as opportunities for young scientists to connect with renowned experts in the field of diabetes research.

💬 “Networking and finding the right mentor, especially at an early stage of your career, is extremely vital. The EASD Early Career Academy supports emerging investigators to accelerate their professional and personal growth and ultimately maintain the passion to pursue excellence in research”, explained Yanislava Karusheva, who wrapped up the Meeting’s highlights.

📺 Watch and read the full wrap up on our EASD e-Learning platform: https://easd-elearning.eu/news/468/EASD-Early-Career-Academy-Meeting-2026.html

14/04/2026

🧠 Meet Prof. Heikki Hyöty (Tampere University), recipient of the /Lilly European Diabetes Research Programme. His research, “Weak innate immune response as a risk factor for enterovirus persistence and insulin-initiated islet autoimmunity” investigates how a reduced innate immune response to enterovirus infections in genetically susceptible individuals may contribute to the development of type 1 diabetes.

The team found that children who later developed type 1 diabetes showed a lower innate immune response to enteroviruses, offering important insight into early disease mechanisms and the link between viral infections and islet autoimmunity.

🗣️ Reflecting on the grant, he shares:
“This support made it possible to address this important research question and generated data which helps to understand the mechanisms of the enterovirus - type 1 diabetes association.”

📖 Read the publication:
https://www.nature.com/articles/s41467-023-42763-9

💡 Explore EFSD programmes:
https://www.europeandiabetesfoundation.org/programmes/

13/04/2026

📺 Have you signed up yet for the joint webinar between EASD Early Career Academy (ECA) and EASOobesity Early Career Network (ECN)? The webinar will show the value of collaboration across diabetes and obesity communities.

Join Prof. Kirsi Pietilainen, 2025 recipient of the EASO - Novo Nordisk Foundation Obesity Prize for Excellence, as she delivers her keynote lecture reflecting on how advances in metabolic care inform care for people living with diabetes and obesity.

📅 14 April 2026 | 🕛 17:00 CEST

Don't miss out. Register now 👉 https://us02web.zoom.us/webinar/register/WN_uhjgn9bnRSuUFthWm5FmIw #/registration

10/04/2026

🎙️ What’s next for anti-obesity medications?

Today's podcast episode features experts Dr. Daniela Liśkiewicz and Dr. Juan Pablo Frías exploring the future of obesity treatment: from GLP-1 therapies and oral drugs to multi-agonists and highly targeted approaches.

The conversation goes beyond weight loss, focusing on long-term health, weight maintenance, and the importance of combining pharmacotherapy with lifestyle change.

🎧👉 Listen now and discover what’s coming next in obesity and diabetes care: https://www.easd.org/media-centre/podcasts/

09/04/2026

📣 Exciting news for early-career clinicians, scientists and public health professionals!

Our EASD Early Career Academy (ECA) is joining forces with the EASOobesity Early Career Network (ECN) for a joint webinar on the value of collaboration across the obesity and diabetes communities.

📅 Tues, 14 April 2026 | ⏰ 17:00 - 18:00 CEST

Prof Kirsi Pietiläinen (Finland), Professor of Clinical Metabolism and 2025 recipient of the EASO - Novo Nordisk Foundation Obesity Prize for Excellence, will explore how advances in metabolic research can inform care for people living with obesity & diabetes and how cross-disciplinary collaboration has shaped her career.

The session will also feature early-career representatives from both the EASD ECA and EASO ECN sharing opportunities for collaboration and professional development at the intersection of obesity and diabetes.

🔗 Register now: https://easo.org/easo-ecn-easd-eca-joint-webinar-collaborating-across-obesity-and-diabetes/

The EASO Early Career Network (ECN) and the EASD Early Career Academy (ECA) invite delegates to a joint webinar on the value of collaboration across obesity and diabetes communities. Date: Tuesday, 14 April 2026 Time: 4-5pm UK / 5-6pm Paris Professor Kirsi Pietiläinen (Finland), Professor of Clinic...

09/04/2026

Our team just wrapped up a site visit in Milan 🇮🇹✈️

Our Managing Director Manja Deparade-Oertel and Conference Manager Brian Carey travelled to the Mico Milano Convention Centre in the heart of Milan - to make sure everything is on track for our annual meeting this September.

Being on the ground always brings a different perspective and hard hats on the table means business! Watch this space for more updates 👀

You can still register for the 62nd EASD Annual Meeting in Milan - https://www.easd.org/annual-meeting/easd-2026/registration/

09/04/2026

📢 European diabetes researchers, this one's for you 🫵 The and Japan Diabetes Society (JDS) Reciprocal Travel Research Fellowship is now open for applications. This is your opportunity to take your diabetes research to Japan, collaborate with world-class scientists, and grow as a researcher.

✅ Up to ¥5,000,000 for applicants from Japan / ✅ Up to €50,000 for applicants from Europe
✅ Up to 12 months at a leading research institution
✅At a leading host institution in Japan.

Wondering what the experience is really like? Dr. Tetiana Yatsenko, from the Palladin Institute of Biochemistry of NAS of Ukraine, did exactly this! She joined 順天堂/Juntendo University in Tokyo to investigate PAI-1 regulation in diabetic kidney disease. Her work has led to 6 publications and insights that could shape personalised treatment approaches. All of this while navigating the realities of the war in Ukraine

📅 Deadline: 1 July 2026 | 🕛 12:00 CEST

🎥 👇 Hear her story in her own words. If her experience resonates with you, we encourage you to apply.

🔗 https://www.europeandiabetesfoundation.org/programmes/programme-calls/efsd-jds-reciprocal-travel-research-fellowship-programme/

08/04/2026

👋 The first EASD Immunology School for Endocrinology brought together around 30 early-career physicians from across Europe in Vienna at a pivotal moment in type 1 diabetes care.

⏳ In two days, chantal mathieu, Colin Dayan, Parth Narendam, Roberto Malone, Lorenzo Piemonti and Manuela Battaglia delivered an intensive, interactive programme focused on immunological basics of type 1 diabetes, “translating research projects on screening for presymptomatic type 1 diabetes into our healthcare systems, and also how to organise the administration of disease-modifying therapies,” as a stepping stone towards the prevention-therapies we hope the near future will bring.

📺 Watch our brief wrap up with the key messages and participant voices from the inaugural EASD Immunology School for Endocrinology on our EASD e-Learning platform: https://easd-elearning.eu/news/467/1st-EASD-Immunology-School-for-Endocrinology.html

Innodia

08/04/2026

📢 We’re pleased to support the upcoming webinar for the important initiative from the “its in your hands” project. Their webinar offers organisations, healthcare professionals, and patient groups practical support to start early type 1 diabetes awareness campaigns. We encourage our community to register and get involved.

📅 5 May 2026 |🕛 13:00 - 14:30 CEST

Register here 👉 6f691d41-cb13-4d32-85e8-a8e7fd327b16@3973589b-9e40-4eb5-800e-b0b6383d1621" rel="ugc" target="_blank">https://events.teams.microsoft.com/event/6f691d41-cb13-4d32-85e8-a8e7fd327b16@3973589b-9e40-4eb5-800e-b0b6383d1621

07/04/2026

🧠 Meet Dr. Borja Martinez-Tellez (Universidad de Almería), recipient of the Rising Star Research Fellowship. Could humans have an unrecognised brown fat depot?

His research focuses on adipose tissue in the dorsocervical region, where early findings suggest it may be denser, more vascularised and metabolically distinct with potential features of thermogenic (brown) fat. If confirmed, this discovery could open new avenues for understanding energy metabolism and developing new strategies for type 2 diabetes.

🗣️ he shares:
“This has been a very important grant. When transitioning from a postdoctoral position to an early-career PI role, securing the first independent funding is particularly challenging. In this case, the grant allowed us to hire a technician who has supported both me and the rest of the team in conducting the clinical study, which will be completed in March 2026.”

📄 Read more: https://news.ual.es/ciencia/un-investigador-de-la-ual-gana-el-premio-europeo-rising-star-por-sus-aportaciones-sobre-la-diabetes/
💡 Explore EFSD programmes: https://www.europeandiabetesfoundation.org/programmes/

Grant supported by Novo Nordisk.